UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036170
Receipt number R000041209
Scientific Title A prospective observational study to evaluate the predictive value of a newly developed software, Uni-APA Predictor, that distinguishes patients who can omit adrenal venous sampling for the diagnosis of unilateral primary aldosteronism.
Date of disclosure of the study information 2019/06/01
Last modified on 2020/09/13 22:00:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study to evaluate the predictive value of a newly developed software, Uni-APA Predictor, that distinguishes patients who can omit adrenal venous sampling for the diagnosis of unilateral primary aldosteronism.

Acronym

A prospective observational study to evaluate the predictive value of a newly developed software, Uni-APA Predictor, that distinguishes patients who can omit adrenal venous sampling for the diagnosis of unilateral primary aldosteronism.

Scientific Title

A prospective observational study to evaluate the predictive value of a newly developed software, Uni-APA Predictor, that distinguishes patients who can omit adrenal venous sampling for the diagnosis of unilateral primary aldosteronism.

Scientific Title:Acronym

A prospective observational study to evaluate the predictive value of a newly developed software, Uni-APA Predictor, that distinguishes patients who can omit adrenal venous sampling for the diagnosis of unilateral primary aldosteronism.

Region

Japan


Condition

Condition

aldosterone-producing adenoma

Classification by specialty

Medicine in general Endocrine surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

in preparation

Basic objectives2

Others

Basic objectives -Others

in preparation

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

in preparation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

in preparation

Key exclusion criteria

in preparation

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Koshiro
Middle name
Last name Nishimoto

Organization

Saitama Medical University International Medical Center

Division name

UroOncology

Zip code

350-1298

Address

1397-1 Yamane, Hidaka, Saitama 350-1241, Japan

TEL

+81-42-984-4111

Email

k.nishimoto@keio.jp


Public contact

Name of contact person

1st name Koshiro
Middle name
Last name Nishimoto

Organization

Saitama Medical University International Medical Center

Division name

UroOncology

Zip code

350-1298

Address

1397-1 Yamane, Hidaka, Saitama 350-1241, Japan

TEL

+81-42-984-4111

Homepage URL


Email

k.nishimoto@keio.jp


Sponsor or person

Institute

Saitama Medical University International Medical Center

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University International Medical Center

Address

1397-1 Yamane, Hidaka, Saitama 350-1241, Japan

Tel

042-984-4523

Email

chikens@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学国際医療センター(埼玉県)、横浜労災病院(神奈川県)、練馬光が丘病院(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 02 Month 18 Day

Date of IRB

2019 Year 03 Month 06 Day

Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete

2021 Year 03 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information

none


Management information

Registered date

2019 Year 03 Month 12 Day

Last modified on

2020 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041209


Research Plan
Registered date File name
2020/05/20 実施計画書ver3.pdf

Research case data specifications
Registered date File name

Research case data
Registered date File name